Matlow J.N, Bronskill S.E, Gruneir A., Bell C.M, Stall N.M, Herrmann N., Seitz D.P, Gill S.S, Austin P.C, Fischer H.D et al..  2017.  Use of Medications of Questionable Benefit at the End of Life in Nursing Home Residents with Advanced Dementia. Journal of the American Geriatrics Society. 65(7):1535-1542.

Maxwell C.J, Campitelli M.A, Hogan D.B, Diong C., Austin P.C, Amuah J.E, Lapane K., Seitz D.P, Gill S.S, Gruneir A. et al..  2017.  Frailty, antipsychotics and mortality among community-based older adults with impaired cognition. Pharmacoepidemiology and Drug Safety. 26(Supplement 2):456-457.

Lo A.T, Gruneir A., Bronskill S.E, Bierman A.S.  2015.  Sex Differences in Home Care Performance: A Population-Based Study. Women's Health Issues. 25(3):232-238.

Maxwell C.J, Bronskill S.E, Diong C., Hogan D.B, Patten S.B, Jette N., Marrie R.A.  2015.  Depressive symptom trajectories in older adults with dementia and associated risk of functional decline. Alzheimer's and Dementia. 11(7 SUPPL. 1):P873-P874.

Vu M., Hogan D.B, Patten S.B, Jette N., Bronskill S.E, Heckman G., Kergoat M.J, Hirdes J.P, Chen X., Zehr M.M et al..  2014.  A comprehensive profile of the sociodemographic, psychosocial and health characteristics of Ontario home care clients with dementia. Chronic Dis Inj Can. 34(2-3):132-44.

Maclagan L.C, Bronskill S.E, Guan J., Campitelli M.A, Herrmann N., Lapane K.L, Hogan D.B, Amuah J.E, Seitz D.P, Gill S.S et al..  2018.  Predictors of Cholinesterase Discontinuation during the First Year after Nursing Home Admission. J Am Med Dir Assoc. 19(11):959-966.e4.